Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 236361, 9 pages
http://dx.doi.org/10.1155/2014/236361
Research Article

CpG Island Methylator Phenotype and Prognosis of Colorectal Cancer in Northeast China

1Department of Epidemiology, Public Health College, Harbin Medical University, Harbin, Heilongjiang 150081, China
2Department of Surgery, Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, China

Received 18 February 2014; Accepted 23 July 2014; Published 28 August 2014

Academic Editor: Fumio Imazeki

Copyright © 2014 Xia Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [16 citations]

The following is the list of published articles that have cited the current article.

  • Maria Tintoré, Santiago Grijalvo, Ramon Eritja, and Carme Fàbrega, “Synthesis of oligonucleotides carrying fluorescently labelled O6-alkylguanine for measuring hAGT activity,” Bioorganic & Medicinal Chemistry Letters, 2015. View at Publisher · View at Google Scholar
  • Javed Hussain Choudhury, and Sankar Kumar Ghosh, “Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristi,” Plos One, vol. 10, no. 6, 2015. View at Publisher · View at Google Scholar
  • S. Veganzones, M. L. Maestro, S. Rafael, V. de la Orden, M. Vidaurreta, B. Mediero, M. Espantaleon, J. Cerdan, and E. Diaz-Rubio, “Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis in colorectal cancer patients with microsatellite i,” Tumor Biology, vol. 36, no. 5, pp. 3853–3861, 2015. View at Publisher · View at Google Scholar
  • Jennifer Mun-Kar Ng, and Jun Yu, “Promoter Hypermethylation of Tumour Suppressor Genes as Potential Biomarkers in Colorectal Cancer,” International Journal Of Molecular Sciences, vol. 16, no. 2, pp. 2472–2496, 2015. View at Publisher · View at Google Scholar
  • Akihiro Nishi, Danny A Milner, Edward L Giovannucci, Reiko Nishihara, Andy S Tan, Ichiro Kawachi, and Shuji Ogino, “Integration of molecular pathology, epidemiology and social science for global precision medicine,” Expert Review of Molecular Diagnostics, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Min Jia, Xu Gao, Yan Zhang, Michael Hoffmeister, and Hermann Brenner, “Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review,” Clinical Epigenetics, vol. 8, 2016. View at Publisher · View at Google Scholar
  • C. Gallois, P. Laurent-Puig, and J. Taieb, “Methylator phenotype in colorectal cancer: A prognostic factor or not?,” Critical Reviews In Oncology Hematology, vol. 99, pp. 74–80, 2016. View at Publisher · View at Google Scholar
  • Jin-Hua Yi, Jiang Liu, and Kun-Hua Wang, “CpG island methylator phenotype in colorectal cancer,” World Chinese Journal of Digestology, vol. 24, no. 4, pp. 558–565, 2016. View at Publisher · View at Google Scholar
  • Min Jia, Hermann Brenner, Michael Hoffmeister, Lina Jansen, Esther Herpel, Matthias Kloor, Jenny Chang-Claude, Viola Walter, Katrin Tagscherer, Wilfried Roth, and Hendrik Bläker, “No association of CpG island methylator phenotype and colorectal cancer survival: Population-based study,” British Journal of Cancer, vol. 115, no. 11, pp. 1359–1366, 2016. View at Publisher · View at Google Scholar
  • Harshali Patil, Shailaja Gada Saxena, Colin J. Barrow, Jagat R. Kanwar, Arnab Kapat, and Rupinder K. Kanwar, “Chasing the personalized medicine dream through biomarker validation in colorectal cancer,” Drug Discovery Today, vol. 22, no. 1, pp. 111–119, 2016. View at Publisher · View at Google Scholar
  • Mouna Triki, Tahia Sallemi-Boudawara, Amana Saadallah-Kallel, Rania Abdelmaksoud-Dammak, Slim Charfi, Abdelmajid Khabir, and Raja Mokdad-Gargouri, “Clinical and prognosis value of the CIMP status combined with MLH1 or p16 INK4a methylation in colorectal cancer,” Medical Oncology, vol. 34, no. 8, 2017. View at Publisher · View at Google Scholar
  • Yoshiki Nando, Jiro Watari, Chiyomi Ito, Ken Hara, Takahisa Yamasaki, Takuya Okugawa, Takashi Kondo, Tomoaki Kono, Katsuyuki Tozawa, Toshihiko Tomita, Yoshio Ohda, Tadayuki Oshima, Hirokazu Fukui, Nagahide Matsubara, Naohiro Tomita, Seiichi Hirota, and Hiroto Miwa, “Genetic instability, CpG island methylator phenotype, and proliferative activity are distinct differences between diminutive and small tubular adenoma of the colorectum,” Human Pathology, vol. 60, pp. 37–45, 2017. View at Publisher · View at Google Scholar
  • Li-Fa Li, and Tong Zhou, “Molecular heterogeneity and immunotherapy of colorectal cancer,” World Chinese Journal of Digestology, vol. 25, no. 24, pp. 2187–2199, 2017. View at Publisher · View at Google Scholar
  • Chi Chun Wong, Weilin Li, Bertina Chan, and Jun Yu, “Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers,” Seminars in Cancer Biology, 2018. View at Publisher · View at Google Scholar
  • Farkas Sükösd, Erzsébet Valicsek, Esther Herpel, Csaba Tóth, Peter Schirmacher, and László Tiszlavicz, “Loss of CDX2 gene expression is associated with DNA repair proteins and is a crucial member of the Wnt signaling pathway in liver metastasis of colorectal cancer,” Oncology Letters, vol. 15, no. 3, pp. 3586–3593, 2018. View at Publisher · View at Google Scholar
  • Shailesh M. Advani, Pragati Advani, Stacia M. DeSantis, Derek Brown, Helena M. VonVille, Michael Lam, Jonathan M. Loree, Amir Mehrvarz Sarshekeh, Jan Bressler, David S. Lopez, Carrie R. Daniel, Michael D. Swartz, and Scott Kopetz, “Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis,” Translational Oncology, vol. 11, no. 5, pp. 1188–1201, 2018. View at Publisher · View at Google Scholar